This company is complete nonsense. None of their data has any real relevance to making you live longer. Everything they’ve claimed is misleading—they’re 100% lying. In fact, I’d bet you might even live shorter if you took whatever they’ve been giving to rats and monkeys.
People question the sanity of Don't Die.
What they don't understand is that legitimate age-reversal technology is on its way.
@brian_armstrong and @byersblake are building this at
@newlimit. I'll be one of their first customers. I'm also an investor.
I’m excited to be the Chief AI Officer of @Meta, working alongside @natfriedman, and thrilled to be accompanied by an incredible group of people joining on the same day.
Towards superintelligence 🚀
This administration is holding Harvard accountable for fostering violence, antisemitism, and coordinating with the Chinese Communist Party on its campus.
It is a privilege, not a right, for universities to enroll foreign students and benefit from their higher tuition payments to help pad their multibillion-dollar endowments.
Harvard had plenty of opportunity to do the right thing. It refused.
They have lost their Student and Exchange Visitor Program certification as a result of their failure to adhere to the law.
Let this serve as a warning to all universities and academic institutions across the country.
Prime Medicine, known for its goal of treating hundreds of diseases with CRISPR, says it's narrowing its focus to two. It also announced big layoffs and a new CEO. https://t.co/iDH7A8GVZR
@zhaoweiasu The reporter included a link to the NEJM article on base editing in the main text. Using “CRISPR” here as a keyword makes sense—I don’t see anything inappropriate about it.
What began as a radical idea – CRISPR-Cas9, a gene editing tool developed by Jennifer Doudna and Emmanuelle Charpentier – has now become a real-world cure.
Read more: https://t.co/pv67bqCFSS